Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 18;191(6):1012-1013.
doi: 10.1093/bjd/ljae289.

Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

Angelo Li  1 , Annelie H Musters  1 , Ariënna Hyseni  1 , Louise A A Gerbens  1   2 , Phyllis I Spuls  1   2
Affiliations

Dupilumab-associated (hyper)eosinophilia in patients with atopic dermatitis: a single-centre cohort study of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registry

Angelo Li et al. Br J Dermatol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest LAAG is one of the main investigators of the TREAT NL registry. She has no further conflicts of interest. PIS has done consultancies in the past for Sanofi (111017) and AbbVie (041217) (unpaid), has received departmental independent research grants from pharmaceutical industries since December 2019 for the TREAT NL registry, is involved in performing clinical trials with many pharmaceutical companies that manufacture drugs used for the treatment of, for example, psoriasis and atopic dermatitis, for which financial compensation is paid to the department/hospital and, is chief investigator of the Systemic and Phototherapy Atopic Eczema Registry (TREAT NL) for adults and children and one of the main investigators of the SECURE-AD registry. The other authors do not list any conflicts of interest.